Literature DB >> 19128667

Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.

Danuta Suchozebrska-Jesionek1, Marcin Szymański, Jacek Kurzepa, Wiesław Gołabek, Marta Stryjecka-Zimmer.   

Abstract

BACKGROUND: Cholesteatoma of the middle ear or mastoid is a hyperproliferative disorder of keratinocytes characterized by a progressive bone erosion. Matrix metalloproteinase (MMP)-2 and MMP-9 gelatinases are endopeptidases targeting extracellular protein. Several studies examined the role of gelatinases in the pathogenesis of cholesteatoma, but the biologic mechanism by which cholesteatoma destroys the bone tissue remains unclear.
OBJECTIVES: The aim of this study was to characterize the activity of MMP-2 and MMP-9 in human cholesteatoma and external auditory canal skin.
METHODS: In the study, specimens of cholesteatoma and middle ear canal skin from 14 patients treated surgically at the Department of Otolaryngology were used. After two-step extraction of MMP-2 and MMP-9 from tissue samples, gelatinolytic activity was assessed with zymography.
RESULTS: We noticed the augmentation of MMP-9 (p = .0001) and MMP-2 (p = .046) activity obtained from cholesteatoma in comparison with control skin. The MMP-9 active to latent ratio was significantly higher in cholesteatoma samples versus normal skin.
CONCLUSION: The present study indicates that MMP-9 and, to a lesser degree, MMP-2 overexpression may be implicated in the molecular mechanisms of cholesteatoma invasion and bone destruction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19128667

Source DB:  PubMed          Journal:  J Otolaryngol Head Neck Surg        ISSN: 1916-0208


  7 in total

Review 1.  The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Xiaoli Wang; Jihao Ren; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-16       Impact factor: 2.503

2.  Post-operative hearing among patients with labyrinthine fistula as a complication of cholesteatoma using "under water technique".

Authors:  K Thangavelu; R Weiß; J Mueller-Mazzotta; M Schulze; B A Stuck; K Reimann
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-20       Impact factor: 3.236

3.  Remodeling Factors, Transcription Factors and Angiogenetic Factors in Cholesteatoma in Ontogenetic Aspect.

Authors:  Kristaps Dambergs; Gunta Sumeraga; Māra Pilmane
Journal:  Iran J Otorhinolaryngol       Date:  2022-03

4.  Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.

Authors:  Taichi Kan; Hiromi Ueda; Taishi Takahara; Yoshimasa Tsuchiya; Mayuko Kishimoto; Yasue Uchida; Tetsuya Ogawa; Wataru Ohashi; Toyonori Tsuzuki; Yasushi Fujimoto
Journal:  Biomed Res Int       Date:  2021-03-10       Impact factor: 3.411

Review 5.  Endotyping of Cholesteatoma: Which Molecular Biomarkers? A Systematic Review.

Authors:  Elena Cantone; Claudio Di Nola; Eugenio De Corso; Michele Cavaliere; Giusi Grimaldi; Anna Rita Fetoni; Gaetano Motta
Journal:  J Pers Med       Date:  2022-08-21

Review 6.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

7.  Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.

Authors:  Carlos Eduardo Borges Rezende; Ricardo Peres do Souto; Priscila Bogar Rapoport; Laís de Campos; Marcela Bovo Generato
Journal:  Braz J Otorhinolaryngol       Date:  2012-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.